Investorideas.com


Be a guest or sponsor our podcasts - learn more about us : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 416 (OTC: CSUI) (OTC: SIML) (CSE: MWM) (TSXV: KHRN) (OTCQX: KHRNF) (CSE: THC) (OTC: THCBF)

 

Delta, Kelowna, BC - May 20, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/052020-StocksToWatch.mp3

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 415 (OTC: CSUI) (CSE: MWM) (TSXV: KHRN) (OTCQX: KHRNF) (CSE:THC) (OTC:THCBF)

SHARE PODCAST:      

Hear the investor ideas potcast on Spotify

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today's podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.

In today's podcast we will be looking at a few public company announcements.

Simlatus Corporation (OTC: SIML) announced today that the company has completed its testing and will move forward with Proscere Bioscience's CBD coldwater extraction systems and initial $20M in orders.

Under COVID19 rules, the company audit for the year ending 12/31/2019 is completed and scheduled for filing, and the quarter ending 3/31/2020 will follow shortly.

Richard Hylen, CEO, stated, "The Company has endured the COVID19, and can proceed forward in 2 weeks in completing CBD coldwater extraction purchase orders. We have new interest from commercial players in the CBD industry who is now seeking quotes. Proscere Bioscience will spearhead the revenue for our company. Our subsidiaries, Satel and our Simlatus broadcast systems, continue to produce revenue as a part of our diversification. All of our companies show extreme promise in growing revenues this year."

The company operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry. Proscere Bioscience manufactures the first commercial industry standard cold-water CBD extraction system for medical grade cannabis utilization, along with their aeroponic commercial grade technology control containers for government food-safety programs, commercial and medical grade CBD. Satel Group is the premier high-rise DirecTV providers in the San Francisco metropolitan area, and is now expanding both DirecTV and Internet services across the SF Bay Area. Simlatus manufactures its own proprietary systems for the major broadcast studios, such as Warner Bros., Fox News, CBS and DirecTV. Its video technology is the major system used for underwater oil exploration in the world.

Micron Waste Technologies Inc. (CSE: MWM) (OTC: MICWF) announced that it has entered into a Definitive Purchase Agreement with the shareholders of Covid Technologies Inc. for the acquisition of all of the shares of Covid.

Since announcing the interim agreement with Covid on April 20, 2020, the Company has been completing diligence on Covid, the personal protection equipment ("PPE") industry and anticipated demand for PPE. The Company is of the view that the demand for PPE will increase in the future as Canadian and worldwide economies, education and securities re-open. The anticipated demand for PPE the Company believes will transcend the current need arising from the pandemic and will become a requirement of the "new normal". Covid has established manufacturing capacity through the acquisition of state-of-the-art mask making equipment, including the purchase of a FLK120 surgical mask making machine and over 5 tonnes of raw material for mask production. Covid has additional cash and manufacturing assets having a replacement value of approximately $500,000. Since the interim agreement, Covid has entered into purchase agreements for approximately 1 million masks to private enterprise.

Following closing of the purchase and sale, Covid will relocate its manufacturing facilities to the Delta, BC facilities of Micron and be managed by the existing Micron team, together with Covid founder Harveer Sidhu.

Micron will continue the research and development of its Cannavore, Pharmavore and Organivore waste digesters from its Delta facilities. In particular, the Pharmavore digestor is anticipated to enter testing and trials with an industry partner in Q2 2020.

The Company has in excess of $3M to allocate to its waste digestor business and it is anticipated that the PPE business line will be self-financing based on anticipated sales.

Closing of the acquisition is anticipated to be completed by the end of May 2020.

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced that it has received authorization from Colombia's National Narcotics Fund for the sale of magistral preparation of high-THC medical cannabis. With this authorization Khiron becomes the first and, to date, only company fully authorized to manufacture and sell high-THC medical cannabis for patient prescriptions in Colombia.

"The authorization from Colombia's National Narcotics Fund demonstrates our continued ability to meet regulatory requirements, and as a result we today begin to sell high-THC medical cannabis product in Colombia. With our clinics, training and infrastructure in place our high-THC product offers an important alternative for patients living with chronic pain, nausea and vomiting associated with chemotherapy, and continues Khiron's mission to improve the quality of life for patients in Colombia and across Latin America," comments Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs.

Initial high-THC product prescriptions under the National Narcotics Fund authorization will be filled through the Company's fully owned ILANS clinics which are in receipt of high-THC dispensary authorization. Distribution will expand as Khiron's Colombian pharmacy partners receive dispensing authorization, which is anticipated in Q3 2020.

THC BioMed Intl Ltd. (CSE:THC) (OTC:THCBF) announced that it will begin this week to ship its ready-to-drink Cannabis Beverage Shot, THC KISS, to the legal adult recreational cannabis market.

THC BioMed's first shipment of THC Kiss will head to Saskatchewan, with shipments to B.C. and Ontario currently undergoing fulfilment.

THC KISS is a brand new Cannabis Beverage Shot that promises to offer a different experience compared to edibles and beverages currently available in either the grey or legal cannabis markets.

THC Kiss aims to be an alternative to smoking cannabis and was developed by THC BioMed using proprietary extraction methods invented by THC BioMed.

"We have received very positive feedback on THC Kiss from our medical patients, with repeat orders per client increasing substantially. We are proud to bring Canadians a true alternative to smoking cannabis," commented John Miller, President and CEO.

Each 30ml bottle of THC Kiss contains 10 mg of THC.

Once again, today's podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

Disclosure- CSUI is a paid monthly news and social media client /More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories